Award
NIH Reporter #5R01AI184895-03
Multivalent mRNA-based malaria vaccines
Recipient
Drexel University, Philadelphia, PA
Award Amount
$718,445.00
Ceiling
$718,445.00
Awarded
July 24, 2026
Identifier
5R01AI184895-03
This award funds research to develop a multivalent mRNA-based malaria vaccine targeting multiple parasite stages to improve efficacy and durability.
Description
The project focuses on evaluating mRNA technology for delivery of a malaria vaccine designed to elicit responses against multiple parasite stages. It aims to optimize mRNA vaccines targeting P. falciparum and P. vivax malaria, including candidates like PfCSP, PfRh5, and PfMSP119, to develop a multicomponent malaria vaccine.